Poliomyelitis Completed Phase 2 Trials for Meningococcal polysaccharide vaccine group W-135 (DB13887)

Back to Poliomyelitis

Also known as: Polio / Acute poliomyelitis, unspecified / Acute unspecified poliomyelitis / Polio acute / Acute poliomyelitis / Poliomyelitis NOS / Acute poliomyelitis (disorder) / Epidemic acute poliomyelitis (disorder) / Heine-Medin disease / Poliomyelitis (acute) / Poliomyelitis acute

Indication	Status	Phase
DBCOND0013769 (Poliomyelitis)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00355121	Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Meningococcal polysaccharide vaccine group C (DB13890) Meningococcal polysaccharide vaccine group W-135 (DB13887) Meningococcal polysaccharide vaccine group Y (DB13888)